BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ardais Corporation Appoints Donald B. Hawthorne As President And Chief Executive Officer


10/19/2005 5:10:46 PM

LEXINGTON, Mass., Nov. 17 /PRNewswire/ -- Ardais Corporation, a leading clinical genomics company that provides products and services for drug discovery, appointed Donald B. Hawthorne President and Chief Executive Officer and member of the Company's Board of Directors. Mr. Hawthorne has held leadership positions in the healthcare industry for over 20 years, and has extensive experience in growing emerging companies. He replaces Gregory D. Phelps, who left Ardais to pursue other opportunities.

William Mills, Partner, Advent International; member, Board of Directors, Ardais Corporation, stated, "The application of human disease to drug discovery, known as clinical genomics, is a rapidly emerging field. Ardais has already made a significant impact in this area through collaborations with pharmaceutical and biotech partners, and we are excited about additional near- term business opportunities, which we are developing."

Since 1999, Mr. Hawthorne has been a contract operating partner to the healthcare venture capital community, providing general management and strategic advisory services. Formerly, he was a Partner and Chief Financial Officer at Ampersand Ventures, a private equity firm. Mr. Hawthorne holds an MBA from the Stanford Graduate School of Business.

About Ardais Corporation

Ardais Corporation, a privately held clinical genomics company, is dedicated to enhancing and accelerating biomedical research by applying actual human disease as the discovery model in pharmaceutical research and development. The Ardais BIGR(R) System encompasses a unique and growing biorepository, called the BIGR(R) Library, of more than 180,000 Research- Quality tissue samples and associated clinical data from more than 14,000 donors, representing a broad diversity of disease states. The Company recently announced the availability of its BIGR(R) Biospecimen Management System (BMS), a comprehensive set of services and licenses that enable biomedical researchers in pharmaceutical, biotechnology and academic medical research institutions to collect, annotate, manage and distribute their human biological material resources. For more information, please visit http://www.ardais.com/.

Contacts: Christine Mackenzie Communications Associate Ardais Corporation (781) 274-6420 Francesca T. DeVellis Vice President Feinstein Kean Healthcare (617) 577-8110

Ardais Corporation

CONTACT: Christine Mackenzie, Communications Associate of ArdaisCorporation, +1-781-274-6420; or Francesca T. DeVellis, Vice President ofFeinstein Kean Healthcare, +1-617-577-8110



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES